119 related articles for article (PubMed ID: 8860111)
1. Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients.
Pancera P; Arosio E; Minuz P; Pirante F; Ribul M; Lechi A
Prostaglandins Leukot Essent Fatty Acids; 1996 Mar; 54(3):217-22. PubMed ID: 8860111
[TBL] [Abstract][Full Text] [Related]
2. Amlodipine and haemodynamic effects of cyclo-oxygenase inhibition.
Minuz P; Pancera P; Ribul M; Priante F; Degan M; Campedelli A; Arosio E; Lechi A
Br J Clin Pharmacol; 1995 Jan; 39(1):45-50. PubMed ID: 7756098
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders.
Vainio M; Riutta A; Koivisto AM; Mäenpää J
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1119-23. PubMed ID: 15548142
[TBL] [Abstract][Full Text] [Related]
4. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
[TBL] [Abstract][Full Text] [Related]
5. Urinary prostaglandin excretion in pregnancy: the effect of dietary sodium restriction.
Delemarre FM; Thomas CM; van den Berg RJ; Jongsma HW; Steegers EA
Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):209-15. PubMed ID: 11049696
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ
Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950
[TBL] [Abstract][Full Text] [Related]
7. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
8. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects.
Kudolo GB; Dorsey S; Blodgett J
Thromb Res; 2002 Nov; 108(2-3):151-60. PubMed ID: 12590952
[TBL] [Abstract][Full Text] [Related]
9. An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A.
Förstermann U; Kühn K; Vesterqvist O; Gréen K; Frei U; Brunkhorst R; Haas J; Koch KM; Frölich JC
Prostaglandins; 1989 May; 37(5):567-75. PubMed ID: 2662262
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
11. Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs.
Rautanen M; Gullichsen E; Riutta A; Kuttila K; Mucha I; Nelimarkka O; Niinikoski J
Crit Care Med; 1997 Jul; 25(7):1215-21. PubMed ID: 9233750
[TBL] [Abstract][Full Text] [Related]
12. Reduced excretion of vasodilator prostaglandins in preeclampsia.
Minuz P; Covi G; Corsato M; Probitzer P; Spiazzi L; Paluani F; Degan M; Lechi C; Lechi A
Agents Actions Suppl; 1987; 22():175-81. PubMed ID: 3324706
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
14. Altered excretion of prostaglandin and thromboxane metabolites in pregnancy-induced hypertension.
Minuz P; Covi G; Paluani F; Degan M; Lechi C; Corsato M; Lechi A
Hypertension; 1988 Jun; 11(6 Pt 1):550-6. PubMed ID: 3290103
[TBL] [Abstract][Full Text] [Related]
15. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children.
Leonhardt A; Busch C; Schweer H; Seyberth HW
Acta Paediatr; 1992 Mar; 81(3):191-6. PubMed ID: 1511190
[TBL] [Abstract][Full Text] [Related]
16. Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
Stichtenoth DO; Marhauer V; Tsikas D; Gutzki FM; Frölich JC
Kidney Int; 2005 Nov; 68(5):2197-207. PubMed ID: 16221219
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin biosynthesis in essential hypertension before and during treatment.
Ritter JM; Brett SE; Woods JD; Benjamin N; Stratton PD; Barrow SE
J Hum Hypertens; 1996 Jan; 10(1):37-42. PubMed ID: 8642189
[TBL] [Abstract][Full Text] [Related]
18. Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet.
Schwartz JI; Thach C; Lasseter KC; Miller J; Hreniuk D; Hilliard DA; Snyder KM; Gertz BJ; Gottesdiener KM
J Clin Pharmacol; 2007 Dec; 47(12):1521-31. PubMed ID: 17925592
[TBL] [Abstract][Full Text] [Related]
19. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
[TBL] [Abstract][Full Text] [Related]
20. The impact of prostanoids on pulmonary gas exchange during abdominal surgery with mesenteric traction.
Brinkmann A; Seeling W; Wolf CF; Kneitinger E; Vogeser F; Rockemann M; Brückner U; Radermacher P; Büchler M; Georgieff M
Anesth Analg; 1997 Aug; 85(2):274-80. PubMed ID: 9249099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]